Jeffrey Goshe
Ophthalmology · Cleveland, OHNPI 1487828943
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $66,740 of the $82,077 with a category attached, or 81.3%. Dompe US, Inc. accounts for 97.8% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $46,061, more than ten times the $2,645 reported in 2019. Among ophthalmology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 152 payments — averaging $539.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dompe US, Inc.$80K
- Carl Zeiss Meditec, Inc.$2K
- Alcon$252
- Carl Zeiss Meditec USA, Inc.$28
- Biotissue Holdings Inc.$23
What the payments were for
- Speaking & faculty fees$66,74081%
- Travel & lodging$12,66415%
- Food & beverage$2,6743%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dompe US, Inc. | 137 | $80,275 |
| Carl Zeiss Meditec, Inc. | 1 | $1,500 |
| Alcon | 12 | $252 |
| Carl Zeiss Meditec USA, Inc. | 1 | $28 |
| Biotissue Holdings Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Oxervate$77,998
- OPMI Lumera 700$1,500
How this compares
$82,077 in reported general payments places this provider in the 95th percentile of 640 ophthalmology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 658 | $26,662 |
| RestasisCyclosporine | 18 | $21,437 |
| MieboPerfluorohexyloctane/Pf | 14 | $12,408 |
| ValacyclovirValacyclovir Hcl | 163 | $12,187 |
| LumiganBimatoprost | 15 | $8,990 |
| Loteprednol Etabonate | 43 | $7,149 |
| Restasis MultidoseCyclosporine | 11 | $6,934 |
| Difluprednate | 39 | $5,801 |
| Fluorometholone | 64 | $3,661 |
| Alphagan PBrimonidine Tartrate | 13 | $3,630 |
| MoxifloxacinMoxifloxacin Hcl | 106 | $3,396 |
| Ketorolac Tromethamine | 142 | $2,572 |
| ErythromycinErythromycin Base | 85 | $2,333 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 21 | $2,280 |
| Brimonidine Tartrate | 117 | $2,199 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Cleveland
- Peter KaiserCleveland$1.5M
- Justis EhlersCleveland$639K
- Sunil SrivastavaCleveland$508K
- William WileyCleveland$479K
- Yasha ModiCleveland$234K
- Faruk OrgeCleveland$158K
- Danny MammoCleveland$149K
- Douglas RheeCleveland$138K
- William DuppsCleveland$44K
- Shree KurupCleveland$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.